[1]
Matusov Y, Singh I, Yu Y, et al. Chronic thromboembolic pulmonary hypertension: The bedside. Curr Cardiol Rep 2021; 23: 147.
[http://dx.doi.org/10.1007/s11886-021-01573-5]
[http://dx.doi.org/10.1007/s11886-021-01573-5]
[2]
Alba GA, Atri D, Darbha S, et al. Chronic thromboembolic pulmonary hypertension: The bench. Curr Cardiol Rep 2021; 23: 141.
[http://dx.doi.org/10.1007/s11886-021-01572-6]
[http://dx.doi.org/10.1007/s11886-021-01572-6]
[3]
Van de Veerdonk MC, Bogaard HJ, Voelkel NF. The right ventricle and pulmonary hypertension. Heart Fail Rev 2016; 21: 259-71.
[4]
Singh S, Lewis MI. Evaluating the right ventricle in acute and chronic PE: Current and future considerations. Semin Respir Crit Care Med 2021; 42(2): 199-211.
[PMID: 33548932]
[PMID: 33548932]
[5]
Middleton RC, Fournier M, Rogers RG, Grimes BS, Xu X, Lewis MI. Temporal changes in key signal transduction pathways mediating muscle protein synthesis with adaptive and maladaptive right ventricular hypertrophy in pulmonary arterial hypertension. Cardio Open 2023; 8: 296-309.
[6]
Diller GP, Kempny A, Alonso-Gonzalez R, et al. survival prospects and circumstances of death in contemporary adult congenital heart disease patients under follow-up at a large tertiary centre. Circulation 2015; 132: 2118-25.
[PMID: 26369353]
[PMID: 26369353]
[7]
Low TT, Guron N, Ducas R, et al. Pulmonary arterial hypertension in pregnancy-a systematic review of outcomes in the modern era. Pulm Circ 2021; 11: 20458940211013671.
[PMID: 34104423]
[PMID: 34104423]